The Multifaceted Role of Annexin A1 in Colorectal Cancer: From Molecular Mechanisms to Predictive and Prognostic Implications

Annexin A1 (ANXA1), a calcium-dependent phospholipid-binding protein, is considered a key modulator of cancer biology. Numerous pieces of evidence support its multifaceted involvement in tumor progression, metastatic dissemination, immune escape, and resistance to therapy in various malignancies, such as melanoma, along with liver, lung, and digestive tract tumors, including stomach and colorectal cancer (CRC). Although colon and rectal cancer (RC) exhibit overlapping characteristics, they are classified as separate clinical entities due to differences in tumor biology and therapy approaches. Moreover, locally advanced rectal cancer (LARC) raises clinical challenges due to variable treatment responses and its therapy resistance, preventing successful treatment and patients’ recovery. Considering ANXA1’s involvement in chemoresistance, further investigation is currently focused on ANXA1-targeted therapies. This review aims to update the knowledge on ANXA1, as a CRC predictive and prognostic biomarker, with involvement in therapy resistance, highlighting its significance in LARC patients. Through emerging evidence, our research provides valuable insights into the potential of ANXA1’s clinical utility and its prospective value as a target in chemoresistance approaches.

• Publication year

  2025

• Venue

  Medical Science

• Publication date

  2025-11-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/medsci13040263PMID 41283264PMCID 12641671
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with two step feature selection and ensemble learning

  2025cited by this paper
• Biomarkers for colorectal cancer detection: An insight into colorectal cancer and FDA-approved biomarkers

  2025cited by this paper
• 93P MDX-124, a novel anti-ANXA1 antibody, has significant anti-cancer activity in preclinical models of osteosarcoma

  2025cited by this paper
• The Role of Pre-Treatment Inflammatory Biomarkers in Predicting Tumor Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer

  2025influential reference
• Molecular mechanism of angiogenesis in colorectal cancer

  2025cited by this paper
• The Landmark Series: Neoadjuvant Therapy for Locally Advanced Rectal Cancer

  2025cited by this paper
• Anti-EGFR Therapy in Metastatic Colorectal Cancer: Identifying, Tracking, and Overcoming Resistance

  2025cited by this paper
• Advances in colorectal cancer screening and detection: a narrative review on biomarkers, imaging and preventive strategies

  2025cited by this paper
• What Is Next for Refractory Colorectal Cancer CRC? Looking Beyond SUNLIGHT, FRESCO2, RECURSE and CORRECT

  2025cited by this paper
• Radioresistance in rectal cancer: can nanoparticles turn the tide?

  2025cited by this paper
• CD133 and CD166 Stem Cells Markers Expression, Clinicopathological Parameters, and Fragmentation Response Patterns of ypT3 Rectal Cancer Following Neoadjuvant Chemoradiotherapy

  2025cited by this paper
• Therapeutic Management of Locally Advanced Rectal Cancer: Existing and Prospective Approaches

  2025cited by this paper
• Targeting the EGFR signalling pathway in metastatic colorectal cancer.

  2024cited by this paper
• The role of ANXA1 in the tumor microenvironment.

  2024influential reference
• ATTAINMENT: A phase Ib trial of MDX-124, a first-in-class annexin-A1 targeting antibody, alone and in combination with anti-cancer treatments, in patients with advanced solid tumors.

  2024cited by this paper
• An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review)

  2024influential reference
• Navigating the Interplay between BCL-2 Family Proteins, Apoptosis, and Autophagy in Colorectal Cancer

  2024cited by this paper
• A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo

  2024influential reference
• Rectal Cancer: Exploring Predictive Biomarkers Through Molecular Pathways Involved in Carcinogenesis

  2024cited by this paper
• Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy

  2024influential reference
• Annexins—a family of proteins with distinctive tastes for cell signaling and membrane dynamics

  2024cited by this paper
• Cracking the code of Annexin A1-mediated chemoresistance.

  2024influential reference
• Factors associated with pathological complete remission after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a real-world clinical setting

  2024cited by this paper
• Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy

  2024cited by this paper
• Future direction of total neoadjuvant therapy for locally advanced rectal cancer

  2024cited by this paper
• The Impact on Survival of Neoadjuvant Treatment Interruptions in Locally Advanced Rectal Cancer Patients

  2024cited by this paper
• Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success

  2024cited by this paper
• Potential use of SCAT1, SCAT2, and SCAT8 as diagnostic and prognosis markers in colorectal cancer.

  2024influential reference
• Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer

  2024cited by this paper
• STAT3 and the STAT3‑regulated inhibitor of apoptosis protein survivin as potential therapeutic targets in colorectal cancer (Review)

  2024cited by this paper
• Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial.

  2024influential reference
• Functional proteomics of colon cancer Consensus Molecular Subtypes

  2024cited by this paper
• Management of Locally Advanced Rectal Cancer: ASCO Guideline

  2024cited by this paper
• Evaluation of annexin A1 expression in lung, breast, colon, and prostatic adenocarcinomas and in tumor microenvironment

  2023cited by this paper
• The Role of Annexin A1 in DNA Damage Response in Placental Cells: Impact on Gestational Diabetes Mellitus

  2023cited by this paper
• Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer

  2023influential reference
• Multi-Faceted Role of Cancer-Associated Adipocytes in Colorectal Cancer

  2023cited by this paper
• Novel biomarkers to predict treatment response and prognosis in locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy

  2023cited by this paper
• Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR

  2023cited by this paper
• Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis

  2023cited by this paper
• Neutrophil Extracellular Trap is Surrogate Biomarker for Prognosis and Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer

  2023cited by this paper
• ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers

  2023cited by this paper
• Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer

  2023cited by this paper
• The past, present, and future of immunotherapy for colorectal cancer

  2023cited by this paper
• Immunotherapies targeting tumor vasculature: challenges and opportunities

  2023cited by this paper
• Total neoadjuvant therapy for rectal cancer: a guide for surgeons

  2023cited by this paper
• Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment

  2023cited by this paper
• Targeting Annexin A1 as a Druggable Player to Enhance the Anti-Tumor Role of Honokiol in Colon Cancer through Autophagic Pathway

  2023influential reference
• Distinct tumor microenvironment landscapes of rectal cancer for prognosis and prediction of immunotherapy response

  2022cited by this paper
• Current concepts of anti-EGFR targeting in metastatic colorectal cancer

  2022cited by this paper
• The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation

  2022cited by this paper
• Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis

  2022cited by this paper
• Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity

  2022cited by this paper
• Annexin‐1 is an oncogene in glioblastoma and causes tumour immune escape through the indirect upregulation of interleukin‐8

  2022cited by this paper
• Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab

  2022cited by this paper
• Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer.

  2022cited by this paper
• The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation

  2022cited by this paper
• Mir-675-5p supports hypoxia-induced drug resistance in colorectal cancer cells

  2022cited by this paper
• Tumor Microenvironment Shapes Colorectal Cancer Progression, Metastasis, and Treatment Responses

  2022influential reference
• Annexin‐A1: The culprit or the solution?

  2022cited by this paper
• Granatin B and punicalagin from Chinese herbal medicine pomegranate peels elicit reactive oxygen species-mediated apoptosis and cell cycle arrest in colorectal cancer cells.

  2022influential reference
• Annexin A1 affects tumor metastasis through epithelial-mesenchymal transition: a narrative review

  2022influential reference
• Strategies to Optimize Treatment for Locally Advanced Rectal Cancer

  2022cited by this paper
• Comprehensive evaluation of the tumor immune microenvironment and its dynamic changes in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy: From the phase II ADORE study

  2022cited by this paper
• Colorectal cancer: the facts in the case of the microbiota

  2022cited by this paper
• A Cell-Based Systematic Review on the Role of Annexin A1 in Triple-Negative Breast Cancers

  2022cited by this paper
• RRM2 Regulates Sensitivity to Sunitinib and PD‐1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway

  2021cited by this paper
• Advances in cancer treatment: a new therapeutic target, Annexin A2

  2021cited by this paper
• ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer

  2021cited by this paper
• The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials

  2021cited by this paper
• Predicting treatment response from longitudinal images using multi-task deep learning

  2021cited by this paper
• Knockdown of Annexin-A1 Inhibits Growth, Migration and Invasion of Glioma Cells by Suppressing the PI3K/Akt Signaling Pathway

  2021cited by this paper
• Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy.

  2021cited by this paper
• ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation

  2021cited by this paper
• Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway

  2021cited by this paper
• Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

  2021cited by this paper
• The Association of Annexin A1 and Chemosensitivity to Osimertinib in Lung Cancer Cells

  2021cited by this paper
• Targeting STAT3 Signaling Pathway in Colorectal Cancer

  2021cited by this paper
• Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors

  2021cited by this paper
• Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF-κB/BCL-2 Signaling Pathway In Vitro and In Vivo

  2021cited by this paper
• Short-Course Radiotherapy versus Long-Course Radio-Chemotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer: Meta-Analysis from a Toxicity Perspective.

  2021cited by this paper
• Annexin Animal Models—From Fundamental Principles to Translational Research

  2021influential reference
• New insight into the role of ANXA1 in melanoma progression: involvement of stromal expression in dissemination.

  2021cited by this paper
• Annexin A1 as a Regulator of Immune Response in Cancer

  2021influential reference
• Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5‐fluorouracil combination induction chemotherapy in oral squamous cell carcinoma

  2021cited by this paper
• Annexin A1 Expression Is Associated with Epithelial–Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer

  2021cited by this paper
• Total neoadjuvant therapy (TNT) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis.

  2021cited by this paper
• Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer

  2021influential reference
• The Tumor Microenvironment

  2020cited by this paper
• Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancer

  2020cited by this paper
• The multidisciplinary management of rectal cancer

  2020cited by this paper
• Punicalagin Regulates Apoptosis-Autophagy Switch via Modulation of Annexin A1 in Colorectal Cancer

  2020influential reference
• Annexin A1 is a potential biomarker of bone metastasis in small cell lung cancer

  2020cited by this paper
• The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia

  2020cited by this paper
• Role of the NF-κB signaling pathway in the pathogenesis of colorectal cancer.

  2020influential reference
• BCL-2 family deregulation in colorectal cancer: potential for BH3 mimetics in therapy

  2020cited by this paper
• Heparan sulfate binds the extracellular Annexin A1 and blocks its effects on pancreatic cancer cells.

  2020cited by this paper
• Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes.

  2020cited by this paper
• Annexin A1/Formyl Peptide Receptor Pathway Controls Uterine Receptivity to the Blastocyst

  2020cited by this paper
• ANXA1 Binds and Stabilizes EphA2 to Promote Nasopharyngeal Carcinoma Growth and Metastasis

  2020cited by this paper

• No citing papers are available for this paper.